Found 18 matching trials
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL PHASE3 This is a randomized, open-label, prospective, multicenter phase III superi...
Show More Location
Fudan University Shanghai Cancer Center,
Learn More & Join Trial
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma PHASE2 At present, concurrent chemoradiotherapy (cCRT) with platin-based dual-drug...
Show More Status
Active Not Recruiting
Location
Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Learn More & Join Trial
TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma NA The goal of this clinical trial is to learn if immune microenvironment modi...
Show More Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma PHASE2 This is a prospective, single-center, single-arm, phase II clinical study. ...
Show More Location
Multiple Locations
Learn More & Join Trial
Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma PHASE2 This is a prospective, single-Arm, phase II clinical study evaluating the e...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer PHASE2 Esophageal cancer is a kind of disease with high incidence and mortality. D...
Show More Location
Zhongnan Hospital of Wuhan University
Learn More & Join Trial
A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC PHASE2 The purpose of this study is to observe and evaluate the efficacy and safet...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma NA This is an open-label, single-arm, multi-center Phase II clinical trial eva...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer PHASE3 This study evaluates whether comprehensive local consolidative therapy adde...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC PHASE2 Concurrent chemoradiotherapy -immunotherapy followed by ICI maintenance was...
Show More Learn More & Join Trial